Research progress on inflammatory factor and acute myocardial infarction

Home > Archive>Volume 31, Issue 7, 2023 >639-644

Research progress on inflammatory factor and acute myocardial infarction
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        YANG Qijuan1YANG Qijuan
Graduate School of Qinghai University, Xining, Qinghai 810000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
SU Xiaoling2SU Xiaoling
Department of Cardiology, Qinghai Provincial Peoples Hospital, Xining, Qinghai 810000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:1.Graduate School of Qinghai University, Xi'ning, Qinghai 810000, China;2.Department of Cardiology, Qinghai Provincial People's Hospital, Xi'ning, Qinghai 810000, China)
Clc Number:R5
Fund Project:

Article

Figures

Metrics

Reference [47]

Related [20]

Cited by

Materials

Comments

Abstract:

Acute myocardial infarction is one of the more common clinical cardiovascular diseases,which is based on the occurrence and development of coronary atherosclerosis,and is caused by persistent myocardial ischemia and hypoxia due to thrombosis and plaque rupture,resulting in local myocardial necrosis. Inflammatory factors are involved in the formation and progression of coronary atherosclerotic plaque, and are closely related to the occurrence and development of acute myocardial infarction. This article reviews the research progress of related inflammatory factors in acute myocardial infarction.

Key words:acute myocardial infarction; inflammatory factors; coronary artery disease

Reference

[1] WANG H M, LIU Z F, SHAO J J, et al.Immune and inflammation in acute coronary syndrome:molecular mechanisms and therapeutic implications.J Immunol Res, 0,0:4904217.

[2] TAJBAKHSH A, REZAEE M, KOVANEN P T, et al.Efferocytosis in atherosclerotic lesions:malfunctioning regulatory pathways and control mechanisms.Pharmacol Ther, 8,8:12-25.

[3] DE JAGER S C A, PASTERKAMP G.Crosstalk of lipids and inflammation in atherosclerosis:the PRO of PGRN?.Cardiovasc Res, 3,0(1):4-6.

[4] TIAN R, LI Y, YAO X.PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt/β-Catenin signaling pathway.Inflammation, 6,9(4):1387-1394.

[5] XU X Y, GOU L F, ZHOU M, et al.Progranulin protects against endotoxin-induced acute kidney injury by downregulating renal cell death and inflammatory responses in mice.Int Immunopharmacol, 6,8:409-419.

[6] WANG B C, LIU H, TALWAR A, et al.New discovery rarely runs smooth:an update on progranulin/TNFR interactions.Protein Cell, 5,6(11):792-803.

[7] CHEN X, CHANG J J, DENG Q D, et al.Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells.J Neurosci, 3,3(21):9202-9213.

[8] ALYAHYA A M.The role of progranulin in ischemic heart disease and its related risk factors.Eur J Pharm Sci, 2,5:106215.

[9] KAUR J, MUKHEJA S, VARMA S, et al.Serum progranulin/tumor necrosis factor-α ratio as independent predictor of systolic blood pressure in overweight hypertensive patients:a cross-sectional study.Egypt Heart J, 0,2(1):25.

[10] HWANG H J, JUNG T W, HONG H C, et al.Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-κB pathways.PLoS One, 3,8(9):e76679.

[11] KAWASE R, OHAMA T, MATSUYAMA A, et al.Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice.Cardiovasc Res, 3,0(1):125-133.

[12] TIAN D, QIN Q, LIU R Y, et al.Diagnostic value of circulating progranulin and its receptor EphA2 in predicting the atheroma burden in patients with coronary artery disease.Dis Markers, 1,1:6653501.

[13] WANG J, VAN DAMME P, CRUCHAGA C, et al.Pathogenic cysteine mutations affect progranulin function and production of mature granulins.J Neurochem, 0,2(5):1305-1315.

[14] 王家杰, 王永祥, 彭瑜, 等.血浆颗粒蛋白前体与急性冠状动脉综合征的相关性研究.临床心血管病杂志, 1,7(12):1090-1094.WANG J J, WANG Y X, PENG Y, et al.Correlation between plasma granule protein precursors and acute coronary syndrome.J Clin Cardiol, 1,7(12):1090-1094.

[15] 高夏青, 康玲玲, 李静, 等.老年急性冠状动脉综合征患者血清颗粒蛋白前体水平的变化及意义.中华老年心脑血管病杂志, 2,4(1):34-37.GAO X Q, KANG L L, LI J, et al.Serum progranulin level and its significance in elderly acute coronary syndrome patients.Chin J Geriatr Heart Brain Vessel Dis, 2,4(1):34-37.

[16] ZHOU T, CHEN Y J, ZHANG S H, et al.Serum progranulin as a risk predictor in patients with acute myocardial infarction.Med Sci Monit, 1,7:e928864.

[17] ALYAHYA A M, AL-MASRI A, HERSI A, et al.The effects of progranulin in a rat model of acute myocardial ischemia/reperfusion are mediated by activation of the P13K/Akt signaling pathway.Med Sci Monit Basic Res, 9,5:229-237.

[18] FLENTJE A, KALSI R, MONAHAN T S.Small GTPases and their role in vascular disease.Int J Mol Sci, 9,0(4):917.

[19] 迟正媛, 武维恒.CDC42在缺血再灌注损伤中对内皮细胞凋亡的影响及其机制.中华全科医学, 3,1(9):1334-1335.CHI Z Y, WU W H.Effects of CDC42 on apoptosis of vascular endothelial cells in ischemia/reperfusion injury and mechanism.Chin J Gen Pract, 3,1(9):1334-1335.

[20] 唐碧, 徐庆梅, 朱飞宇, 等.CDC42及YAP检测对非瓣膜性心房颤动诊断的相关性研究.蚌埠医学院学报, 1,6(10):1349-1353.TANG B, XU Q M, ZHU F Y, et al.Correlation between CDC42 and YAP in the diagnosis of nonvalvular atrial fibrillation.J Bengbu Med Coll, 1,6(10):1349-1353.

[21] ITO T K, YOKOYAMA M, YOSHIDA Y, et al.A crucial role for CDC42 in senescence-associated inflammation and atherosclerosis.PLoS One, 4,9(7):e102186.

[22] ZHOU M, WU J, TAN G.The relation of circulating cell division cycle 42 expression with Th1, Th2, and Th17 cells, adhesion molecules, and biochemical indexes in coronary heart disease patients.Ir J Med Sci, 2,1(5):2085-2090.

[23] CHVEZ-SNCHEZ L, GARZA-REYES M G, ESPINOSA-LUNA J E, et al.The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans.Hum Immunol, 4,5(4):322-329.

[24] MURSHID A, GONG J L, PRINCE T, et al.Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activation.PLoS One, 5,0(4):e0122529.

[25] 林应炯.CDC42在泡沫细胞形成和动脉粥样硬化中的作用.南昌:南昌大学, 2020:1-62.LIN Y J.The role of CDC42 in the formation of foam cell and atherosclerosis.Nanchang:Nanchang University, 2020:1-62.

[26] WANG W T, LIU Q, WANG Y, et al.Integration of gene expression profile data of human epicardial adipose tissue from coronary artery disease to verification of hub genes and pathways.Biomed Res Int, 9,9:8567306.

[27] FLORIAN M C, KLENK J, MARKA G, et al.Expression and activity of the small RhoGTPase CDC42 in blood cells of older adults are associated with age and cardiovascular disease.J Gerontol A Biol Sci Med Sci, 7,2(9):1196-1200.

[28] XUE Y, BI F, ZHANG X Y, et al.Role of Rac1 and CDC42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1α activation.Int J Cancer, 6,8(12):2965-2972.

[29] SINGH S, ANSHITA D, RAVICHANDIRAN V.MCP-1:function, regulation, and involvement in disease.Int Immunopharmacol, 1,1(Pt B):107598.

[30] GEORGAKIS M K, BERNHAGEN J, HEITMAN L H, et al.Targeting the CCL2-CCR2 axis for atheroprotection.Eur Heart J, 2,3(19):1799-1808.

[31] XIA Y, FRANGOGIANNIS N G.MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.Inflamm Allergy Drug Targets, 7,6(2):101-107.

[32] DING M, LI M, YANG H L.Clinical diagnostic value of combined detection of IMA, D-D and MCP-1 in acute myocardial infarction.Exp Ther Med, 1,1(5):457.

[33] 徐方芳, 夏雨, 袁伟忠.急性心肌梗死患者血清CSF2RA、MCP-1、GDF-15水平变化及其与病情的相关性.川北医学院学报, 2,7(3):303-6,1.XU F F, XIA Y, YUAN W Z.Expression of CSF2 RA, MCP-1, GDF-15 in serum of patients with acute myocardial infarction and its correlation with disease.J North Sichuan Med Coll, 2,7(3):303-6,1.

[34] SCHIOPU A, BENGTSSON E, GONALVES I, et al.Associations between macrophage colony-stimulating factor and monocyte chemotactic protein 1 in plasma and first-time coronary events:a nested case-control study.J Am Heart Assoc, 6,5(9):e002851.

[35] YAN P, CAO J, ZHOU Y J, et al.Serum levels of sLOX-1 and Lp-PLA2 can predict the prognosis of acute cerebral infarction with a high specificity.Physiol Rep, 2,0(1):e15160.

[36] KATTOOR A J, GOEL A, MEHTA J L.LOX-1:regulation, signaling and its role in atherosclerosis.Antioxidants (Basel), 9,8(7):218.

[37] JIN P F, CONG S Y.LOX-1 and atherosclerotic-related diseases.Clin Chim Acta, 9,1:24-29.

[38] ONER A, AYDINALP A, MDERRISOGˇLU H.Evaluation of hs-CRP and sLOX-1 levels in moderate-to-high risk acute coronary syndromes.Endocr Metab Immune Disord Drug Targets, 0,0(1):96-103.

[39] HUSSEIN R A, ABDUL-RASHEED O F, BASHEER M.Evaluation of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and sLOX-1/oxidized LDL ratio as novel biomarkers of acute coronary syndrome.Acta Biochim Pol, 2,9(2):309-314.

[40] PIRILLO A, CATAPANO A L.Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases.Dis Markers, 3,5(5):413-418.

[41] SCHIRO A, WILKINSON F L, WESTON R, et al.Endothelial microparticles as conveyors of information in atherosclerotic disease.Atherosclerosis, 4,4(2):295-302.

[42] 李梦馨, 庞萌, 李健, 等.预测颈动脉粥样硬化易损斑块的新型生物标志物研究进展.中国动脉硬化杂志, 2,0(8):714-718.LI M X, PANG M, LI J, et al.Research progress of novel biomarkers for predicting vulnerable plaque in carotid atherosclerosis.Chin J Arterioscler, 2,0(8):714-718.

[43] PAUDEL K R, PANTH N, KIM D W.Circulating endothelial microparticles:a key hallmark of atherosclerosis progression.Scientifica (Cairo), 6,6:8514056.

[44] KARKI R, SAHI N, JEON E R, et al.Chungtaejeon, a korean fermented tea, scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells.Plant Foods Hum Nutr, 1,6(1):27-33.

[45] ZHANG Y C, CHENG J J, CHEN F, et al.Circulating endothelial microparticles and miR-92a in acute myocardial infarction.Biosci Rep, 7,7(2):BSR20170047.

[46] YUAN Y J, MAITUSONG M R B, MUYESAI N J I.Association of endothelial and red blood cell microparticles with acute myocardial infarction in Chinese:a retrospective study.Ann Palliat Med, 0,9(4):1564-1570.

[47] 史峥.血清低氧诱导因子-1α、内皮微颗粒水平在急性心肌梗死患者中的表达及意义.河南医学研究, 1,0(2):343-345.SHI Z.Expression and significance of hypoxia-induced factor-1 α and endothelial microparticle in serum of patients with acute myocardial infarction.Henan Med Res, 1,0(2):343-345.

Get Citation

YANG Qijuan, SU Xiaoling. Research progress on inflammatory factor and acute myocardial infarction[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(7):639-644.

Copy

Article Metrics

Abstract:382
PDF: 753
HTML: 0
Cited by: 0

History

Received:November 04,2022
Revised:January 13,2023
Adopted:
Online: September 01,2023
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code